Eli Lilly Director Juan R. Luciano Acquires Deferred Stock Units
ELI LILLY & Co
Subscribe to track LLY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📊 Form 4 Filing: ELI LILLY & Co ($LLY) Insider: Juan R. Luciano (Director) Transaction Date: September 21, 2026 Type: Acquisition (Award / Deferral) Shares Transacted: 13.6637 @ $1,164.89 Total Value: $15,916.71 Shares Owned After: 16,956.8138 Significance: Low (Director Fee Deferral)
Comprehensive Analysis
Executive Summary
On September 22, 2026, Eli Lilly & Co ($LLY) filed a Form 4 disclosing that Director Juan R. Luciano acquired 13.6637 shares of common stock on September 21, 2026. The transaction was executed at a price of $1,164.89 per share, totaling approximately $15,916.71.
Transaction Details
- Security: Common Stock
- Transaction Code: A (Grant, award, or other acquisition)
- Shares Acquired: 13.6637
- Price Per Share: $1,164.89
- Total Consideration: $15,916.71
- Nature of Ownership: Direct
- Post-Transaction Holdings: 16,956.8138 shares
Footnote & Context
Footnote indicates that pursuant to the reporting person's election, these shares were deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan. They will be settled in common stock following the director's separation from service.
Significance Assessment
This transaction is assessed as Low trading significance. It represents a routine, programmatic deferral of director fees into equity rather than an open-market discretionary purchase.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.